CCL17 and pulmonary fibrosis: Further experiments showed that the CCR4 ligand CCL17/TARC (61) plays a role in CCR4-dependent M1 activation leading to iNOS induction and oxidative injury, thereby affecting the development of bleomycin-induced pulmonary fibrosis (62).